Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2011	2017 - 2020
Period Ending	Aug '25 Aug 1, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '11 Jun 30, 2011	2017 - 2020
Market Capitalization	16	7	10	12	17	1	Upgrade
Market Cap Growth	92.82%	-26.34%	-21.22%	-25.97%	1980.46%	300.00%	Upgrade
Enterprise Value	19	11	13	19	17	1	Upgrade
Last Close Price	0.05	0.02	0.03	0.04	0.06	0.04	Upgrade
PE Ratio	27.43	7.61	4.45	-	8.94	-	Upgrade
PS Ratio	4.51	0.93	0.88	1.60	8.29	-	Upgrade
PB Ratio	1.66	0.81	1.40	0.78	1.04	4.67	Upgrade
P/TBV Ratio	2.22	1.34	2.64	4.58	1.07	4.69	Upgrade
P/FCF Ratio	-	2.31	-	17.11	-	-	Upgrade
P/OCF Ratio	-	2.31	-	17.11	-	-	Upgrade
EV/Sales Ratio	5.26	1.47	1.21	2.44	8.45	-	Upgrade
EV/EBIT Ratio	26.57	17.63	5.06	61.89	70.14	-	Upgrade
EV/FCF Ratio	-	3.64	-	25.97	-	-	Upgrade
Debt / Equity Ratio	0.28	0.36	0.54	0.28	0.40	-	Upgrade
Debt / FCF Ratio	-	1.03	-	6.19	-	-	Upgrade
Asset Turnover	0.26	0.60	0.64	0.31	-	-	Upgrade
Inventory Turnover	32.72	75.12	64.81	44.62	-	-	Upgrade
Quick Ratio	0.83	0.47	0.43	0.39	2.76	-	Upgrade
Current Ratio	1.17	0.72	0.55	0.50	2.83	5.21	Upgrade
Return on Equity (ROE)	6.17%	11.91%	19.18%	-5.18%	-	-23.31%	Upgrade
Return on Assets (ROA)	3.17%	3.13%	9.57%	0.77%	-	-7.83%	Upgrade
Return on Capital (ROIC)	3.42%	3.52%	10.70%	0.89%	-	-13.22%	Upgrade
Return on Capital Employed (ROCE)	6.00%	5.70%	27.40%	1.60%	1.10%	-	Upgrade
Earnings Yield	3.65%	13.14%	22.46%	-6.69%	11.18%	-3.08%	Upgrade
FCF Yield	-	43.29%	-84.37%	5.84%	-	-	Upgrade
Buyback Yield / Dilution	-0.27%	-4.73%	-2.85%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.